The Indication is a Canadian pharmaceutical channel-intelligence publication. Analysis is free to read with an account; the Connector (MCP and OpenAI-compatible API) is a paid subscription.
Our analysis is editorial interpretation for industry professionals. It is not legal, financial, medical, or professional advice, and it is not a substitute for your own due diligence. Wire items are machine-assisted and labelled as such.
You are responsible for activity under your account and for keeping your credentials and API tokens secure. Connector access is metered and rate-limited per the plan you subscribe to.
Do not scrape, resell, or redistribute the gated interpretation, and do not use the Connector to build a competing aggregation of our archive. Reasonable, cited reference is welcome.
We may update these terms; material changes will be communicated to account holders. Continued use after an update constitutes acceptance.